tuftsin has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Yoseph, R; Catane, R; Dagan, S; Fridkin, M; Rubinraut, S; Surkis, R; Tzehoval, E | 1 |
| Hart, DA | 1 |
2 other study(ies) available for tuftsin and B16 Melanoma
| Article | Year |
|---|---|
Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Molecular Weight; Neoplasm Transplantation; Polymers; Prodrugs; Trypsin; Tuftsin | 1990 |
Steroids and tuftsin fail to prevent the induction of altered plasma proteinase homeostasis in mice bearing the B16 melanoma or treated with C. parvum.
Topics: Animals; Endopeptidases; Female; Lithium; Melanoma, Experimental; Methylprednisolone; Mice; Mice, Inbred Strains; Propionibacterium acnes; Tuftsin | 1987 |